Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 46,050 shares at $84.07 ($3.1M) on 2022-09-22, disclosed to the SEC on 2022-09-22.
Seasonal sale ($3.1M) by Chairman & CEO — this insider has traded EW in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $84.07 | 16,675 | $1.4M | 45.6% |
| 3 | $84.07 | 16,675 | $1.4M | 45.6% |
| 4 | $84.66 | 3,100 | $262K | 8.5% |
| 5 | $85.26 | 100 | $9K | 0.3% |
| Total | $66.77 avg | 46,050 |
| $3.1M |
| 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |